Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (5) , 1407-1419
- https://doi.org/10.1016/s0149-2918(03)80128-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Randomised comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesisEuropean Journal Of Cancer, 2001
- The Changeable Nature of Patients' Fears Regarding ChemotherapyJournal of Pain and Symptom Management, 2001
- Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice GuidelinesJournal of Clinical Oncology, 1999
- Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.Journal of Clinical Oncology, 1998
- Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonistsBritish Journal of Cancer, 1997
- Effect of postchemotherapy nausea and vomiting on health-related quality of lifeSupportive Care in Cancer, 1997
- On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993Annals of Oncology, 1996
- Management of Cisplatin-lnduced Delayed EmesisOncology, 1996
- Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapyThe Lancet, 1991
- Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.Journal of Clinical Oncology, 1991